Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05520099 · ClinicalTrials.gov registry record

Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform

A clinical trial of Cancer and Colorectal Cancer, sponsored by Elephas.

Recruiting
Registry status
416
Enrollment target
12
Study locations

NCT05520099 is a study of Cancer and Colorectal Cancer that is actively recruiting participants, run by Elephas. The registered enrollment target is 416 participants, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (88% lower). The trial reports 12 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05520099, a study of Cancer and Colorectal Cancer, is actively recruiting participants, sponsored by Elephas.

RECRUITING
Registry status
416 participants
Enrollment target
12
Study locations

Study Summary

The primary objective of this study is to develop and train the Elephas live tumor diagnostic platform and determine the ex-vivo accuracy of the Elephas Score using in-vivo RECIST 1.1 as the reference method

Conditions Studied

Cancer Colorectal Cancer Bladder Cancer Kidney Cancer Urothelial Carcinoma Bladder Immunotherapy MSI-H Colorectal Cancer DMMR Colorectal Cancer Clear Cell Renal Cell Cancer (ccRCC) Head and Neck Cancer (H&N)

Interventions

  • PROCEDURE Core Needle Biopsy, Forceps Biopsy, Punch Biopsy

Study Locations (12)

Florida

  • AdventHealth Orlando - Orlando
  • Memorial Health System - Pembroke Pines
  • Cleveland Clinic Florida - Stuart
  • University of South Florida (Tampa General Hospital) - Tampa

Arkansas

  • CARTI Cancer Center - Little Rock

California

  • Salinas Valley Memorial Healthcare System - Salinas

Kentucky

  • University of Louisville James Graham Brown Cancer Center - Louisville

Maryland

  • Meritus Center for Clinical Research - Hagerstown

New Jersey

  • John Theurer Cancer Center - Hackensack

New York

  • Roswell Park Comprehensive Cancer Center - Buffalo

North Carolina

  • University of North Carolina at Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 416 participants
Start Date 2023-06-26
Est. Completion 2027-01

Sponsor

Elephas

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05520099

The ClinicalTrials.gov registry entry for NCT05520099 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 416 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (88% lower). The listed sponsor is Elephas, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Core Needle Biopsy, Forceps Biopsy, Punch Biopsy is the first listed.

NCT05520099 reports 12 study locations spanning 9 distinct geographic areas - top geographies include Florida, Arkansas, California.

Frequently Asked Questions

What is clinical trial NCT05520099 about?

NCT05520099 is a clinical study titled "Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform". The primary objective of this study is to develop and train the Elephas live tumor diagnostic platform and determine the ex-vivo accuracy of the Elephas Score using in-vivo RECIST 1.1 as the reference method

What is the current status of trial NCT05520099?

This trial is currently recruiting. The enrollment target is 416 participants. The study started on 2023-06-26. Estimated completion is 2027-01.

What conditions does trial NCT05520099 study?

This clinical trial studies the following conditions: Cancer, Colorectal Cancer, Bladder Cancer, Kidney Cancer, Urothelial Carcinoma Bladder.

What interventions are being tested in trial NCT05520099?

The interventions under investigation include: Core Needle Biopsy, Forceps Biopsy, Punch Biopsy (PROCEDURE).

Who is sponsoring clinical trial NCT05520099?

This trial is sponsored by Elephas, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05520099 being conducted?

This trial has 12 study locations across Arkansas, California, Florida, Kentucky, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cancer

All registered trials for this condition

Colorectal Cancer

All registered trials for this condition

Arkansas

All trials with a study site in Arkansas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.